Skip to main content

Peer Review reports

From: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial

Original Submission
16 Jul 2020 Submitted Original manuscript
4 Aug 2020 Author responded Author comments - Farastuk Bozorgmehr
21 Jul 2020 Reviewed Reviewer Report
26 Jul 2020 Reviewed Reviewer Report - Gerard G. Hanna
Resubmission - Version 2
4 Aug 2020 Submitted Manuscript version 2
Publishing
5 Aug 2020 Editorially accepted
26 Aug 2020 Article published 10.1186/s12885-020-07264-8

You can find further information about peer review here.

Back to article page